The non-pharmaceutical dementia treatment options with the strongest evidence are cognitive stimulation therapy, structured exercise, psychosocial and carer-support programmes, sensory and creative therapies, environmental and assistive-technology changes, and photobiomodulation (red and near-infrared light therapy). Each targets a different dimension of living well with dementia: cognition, behaviour, mood, physical function, or quality of life. None of them cure dementia, but the right combination, chosen for the person’s stage and preferences, can meaningfully improve daily life.
Here is what the evidence supports most clearly, and what to do next:
Cognitive stimulation therapy (CST): group-based sessions that improve cognition and quality of life, particularly in mild to moderate dementia.
Structured exercise: walking, strength and balance training that supports function, mood and general health.
Psychosocial and carer-support programmes: counselling, psychoeducation and carer training that reduce distress and improve coping for both the person and their family.
Sensory and creative therapies: music therapy, reminiscence, art and massage that ease agitation, lift mood and increase engagement.
Environmental and assistive-technology changes: home modifications, memory aids and routine adjustments that reduce confusion and improve safety.
Photobiomodulation (PBM): red and near-infrared light therapy used as a supportive adjunct, with emerging evidence for comfort and some cognitive measures.
Immediate next steps: pick one intervention that fits the person’s current stage, record a simple baseline (sleep quality, agitation frequency, or a short cognitive screen), involve the GP or geriatrician, and contact Dementia Australia or My Aged Care for local access.
Pro Tip:Start with the intervention that addresses the most pressing problem right now — agitation, sleep disruption, or social withdrawal — rather than trying to cover every category at once. A focused, measurable trial over six to twelve weeks tells you far more than a scattered approach.
Key takeaways
Evidence-backed non-pharmaceutical dementia treatment options work best when chosen by stage and goal, combined into a multimodal plan, and reviewed regularly with the GP or allied health team.
Point
Details
Start with exercise and CST
Exercise (Grade 1B) and group cognitive stimulation therapy (Grade 2B) have the strongest guideline recommendations for people with dementia.
Set a six to twelve week trial
Pick one or two interventions, record a simple baseline measure, and review with your GP or allied health team at six weeks.
Contact Dementia Australia or My Aged Care
Call 1800 100 500 (Dementia Australia) or 1800 200 422 (My Aged Care) to access local programmes and funded assessments.
Treat red flags as medical, not behavioural
Sudden decline, new neurological signs or severe falls need urgent medical review, not a non-drug trial.
Lifespan Dynamics for PBM support
Lifespan Dynamics supplies red and near-infrared light therapy devices for home and clinical use as a supportive adjunct within a multimodal dementia care plan.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
How practitioners group non-pharmaceutical interventions
Clinicians and researchers organise non-pharmaceutical dementia treatment options into five practical groups, with photobiomodulation emerging as a sixth. Understanding the groups helps you pick the right tool for the right goal.
1. Cognitive interventions target memory, attention and reasoning. Expect modest improvements in cognition and quality of life, typically visible within six to twelve weeks of consistent group sessions.
2. Psychosocial and behavioural approaches address distress, agitation and carer stress. Benefits often appear within four to eight weeks of structured carer training or counselling.
3. Sensory and creative therapies focus on mood, engagement and agitation. Music therapy, for example, can reduce agitation during personal care within the first few sessions.
4. Physical activity and occupational therapy (OT) support physical function, fall prevention and independence in daily activities. Functional gains from exercise programmes typically build over eight to twelve weeks.
5. Environmental and assistive-technology changes reduce confusion, wandering risk and carer burden. Many of these are immediate in effect once implemented.
6. Photobiomodulation uses red and near-infrared light wavelengths to support cellular energy and comfort, with emerging signals for cognitive benefit. It works best as part of a multimodal plan rather than as a standalone therapy.
Statistic callout: The CCCDTD5 expert guideline gives exercise a Grade 1B recommendation and group cognitive stimulation therapy a Grade 2B recommendation for people living with dementia — two of the highest-graded non-drug interventions in any dementia guideline.
The honest framing is this: none of these reliably reverse dementia. What they do, when personalised to the individual’s history, stage and preferences, is help people live better. That is a meaningful goal in its own right.
What are the best non-pharmaceutical dementia treatment options for cognition?
Cognitive stimulation therapy (CST) is the most evidence-backed cognitive intervention for mild to moderate dementia. In plain terms, CST is a structured group programme — usually seven to fourteen weekly sessions — that uses themed activities like word games, current events discussions and sensory exercises to keep the brain engaged. It is not memory drilling; it is social, enjoyable and designed around the person’s strengths.
Cognitive rehabilitation takes a different angle. Rather than general stimulation, it works one-to-one with the person to set specific, personally meaningful goals — relearning how to use a phone, managing a morning routine — and builds strategies to achieve them. It suits mild dementia particularly well.
Memory training (repeated practice of specific memory techniques) has a narrower evidence base and tends to show smaller effects than CST, though it can complement other approaches.
The NCBI evidence review summarises multiple RCTs showing small to moderate short-term benefits from cognitive stimulation, with the caveat that long-term data is limited and study designs vary considerably. Group CST has the most consistent signal.
How to access CST in Australia:
Dementia Australia runs group programmes and can refer you to local providers; call 1800 100 500.
Community memory clinics (attached to major hospitals in most capital cities) offer both assessment and structured cognitive programmes.
My Aged Care (1800 200 422) can arrange an assessment that may fund allied health sessions including cognitive rehabilitation.
Telehealth options have expanded since 2020; ask your GP for a referral to a neuropsychologist or occupational therapist who offers remote sessions.
What to ask before starting a cognitive programme:
What training does the facilitator hold in CST or cognitive rehabilitation?
How many people are in each group, and how are sessions structured?
What outcomes will be measured, and how often?
Is there a minimum commitment period, and what happens if the person’s condition changes?
How do psychosocial approaches reduce distress in dementia?
Behaviours like agitation, repetitive questioning and wandering are rarely random. They are usually communication. The person with dementia is signalling an unmet need — pain, boredom, fear, loneliness — and the most effective response is to identify and address that need rather than suppress the behaviour with medication.
Person-centred care is the foundation of this approach. It means understanding the person’s life history, preferences and values, and using that knowledge to shape every interaction. A person who spent their career as a nurse may respond very differently to being helped with personal care than someone who was a farmer. That context changes everything.
Behavioural management programmes train carers to log the antecedents, behaviour and consequences (the ABC model) of distressing episodes. Once patterns emerge, small environmental or routine changes often reduce the frequency significantly. This is practical, low-cost and teachable.
Psychoeducation and structured carer training programmes — such as those offered through Carer Gateway — give families the skills to manage difficult situations without burning out. The evidence for carer-focused psychosocial support is solid enough that the CCCDTD5 guideline gives it a Grade 2C recommendation.
Practical steps for introducing behavioural strategies at home:
Keep a simple log for one week: time, trigger, behaviour, your response, and outcome.
Identify one recurring pattern and test one small change (a different activity, a change in lighting, a different time of day for personal care).
Run the change for two weeks before judging it.
Share the log with the GP or a psychologist for guidance on next steps.
Pro Tip:Carer burnout is one of the biggest risks in dementia care. Carer Gateway (1800 422 737) offers free counselling, respite planning and peer support — use it before you reach the point of crisis, not after.
Which sensory and creative therapies actually help?
Music therapy has the strongest evidence among sensory therapies. A trained music therapist uses live or recorded music — singing, instrument playing, or simply listening — to reduce agitation, improve mood and increase social engagement. The effect on agitation during personal care is one of the most replicated findings in dementia research. You do not need a formal therapist to start: familiar music from the person’s young adult years, played at a consistent time each day, can noticeably reduce distress.
Reminiscence therapy uses photographs, objects, music and stories from the person’s past to stimulate memory and conversation. It tends to improve mood and engagement rather than cognition directly, and it works well both one-to-one and in small groups. Dementia Australia’s non-pharmacological treatments page lists reminiscence alongside music and dance therapy as commonly used approaches with meaningful quality-of-life benefits.
Art and dance activities follow a similar pattern: moderate evidence for mood and engagement, weaker evidence for cognition, but strong practical value for people who struggle with verbal communication.
Aromatherapy and massage have a smaller evidence base. Both can reduce short-term agitation and improve comfort, particularly for people in moderate to late-stage dementia who may not engage well with verbal therapies. Lavender and lemon balm have the most studied profiles, though the Alzheimer’s Association cautions that no supplement or herbal remedy has consistent high-quality evidence for treating dementia itself.
Bright light therapy vs photobiomodulation: these are different things. Bright light therapy (typically 2,500–10,000 lux white light) targets circadian rhythm disruption and sleep problems, which are common in dementia. Photobiomodulation (PBM) uses specific red (630–670 nm) and near-infrared (810–850 nm) wavelengths at much lower intensities to support cellular energy at the mitochondrial level. Their aims, mechanisms and evidence bases are distinct. Lifespan Dynamics’ devices fall in the PBM category; more on that in the dedicated section below.
Where to find sensory and creative therapies in Australia:
Dementia Australia’s local offices and online programmes
Residential aged care facilities with activity coordinators
Community health centres and day therapy centres funded through My Aged Care
How does exercise and occupational therapy help people with dementia?
Exercise is among the highest-graded non-drug interventions in the CCCDTD5 guideline, based on consistent evidence from multiple RCTs that regular physical activity supports physical function, mood and general health in people living with dementia. The evidence for slowing cognitive decline specifically is less definitive, but the functional and mood benefits alone justify making movement a daily priority.
What kinds of exercise help? Walking programmes are the most accessible starting point. Strength training (light resistance bands or bodyweight exercises) helps maintain muscle mass and reduce fall risk. Balance exercises — standing on one foot, heel-to-toe walking — directly address the fall risk that increases as dementia progresses. Aim for at least 30 minutes of moderate activity on most days, broken into shorter bouts if needed. Starting safely matters more than intensity: begin with what the person can already do comfortably and build gradually.
Occupational therapy (OT) sits alongside exercise as a practical, function-focused intervention. An OT assesses how the person manages daily activities — dressing, cooking, managing medications — and prescribes compensatory strategies and equipment to maintain independence for longer. OT also plays a key role in home safety assessments and assistive technology prescription.
Referral pathways in Australia: ask the GP for a referral to a physiotherapist or OT through a Chronic Disease Management plan (which may cover up to five Medicare-subsidised allied health sessions per year). My Aged Care assessments can also unlock home care packages that fund ongoing allied health support. Community exercise groups specifically designed for older adults with cognitive changes are available through local councils and community health centres in most areas.
Pro Tip:Before starting any new exercise programme, ask the GP to check for cardiovascular risk, osteoporosis and fall history. A simple timed-up-and-go test (standing from a chair, walking three metres, returning and sitting) takes under a minute and gives you a measurable baseline to track progress.
What home changes make the biggest difference for safety?
The environment is a low-cost, high-impact intervention that most families underestimate. Dementia progressively impairs the ability to interpret complex or unfamiliar environments, so simplifying the home reduces confusion, agitation and accident risk without any clinical referral needed.
Dementia-friendly home principles: familiarity over novelty, reduced clutter, clear visual cues, consistent routines, and good lighting. A person with dementia navigates their world largely through habit and recognition. Rearranging furniture, even with good intentions, can be genuinely disorienting.
Safety checklist for the home:
Lighting: increase brightness in hallways, bathrooms and stairwells; use nightlights on the path to the toilet.
Trip hazards: remove loose rugs, secure electrical cords, clear pathways between frequently used rooms.
Bathroom safety: install grab rails near the toilet and shower, use a non-slip bath mat, consider a shower chair.
Signage: label cupboards, drawers and rooms with simple words or pictures.
Wandering risk: door alarms, GPS trackers and door handle covers can reduce exit risk without full restriction.
Assistive technology worth considering includes medication reminder devices (automated dispensers with alarms), large-button phones, movement sensors that alert carers to unusual activity, and electronic calendars with voice reminders. The evidence base for specific devices is limited, but practical benefit in daily life is well-documented by OTs and carers.
Funding and support in Australia: a My Aged Care assessment can fund an OT home safety assessment and equipment prescription. Local council programs (under the Commonwealth Home Support Programme) often cover minor home modifications. Ask the OT for a written report — it is frequently the document that unlocks funding.
Pro Tip:The single most underrated environmental intervention is a consistent daily routine. Predictable mealtimes, activity times and bedtimes reduce agitation because the person’s nervous system learns what to expect. A calm, unhurried carer presence reinforces that predictability in a way no device can replicate.
How do you choose the right intervention for your situation?
The right non-drug approach depends on four things: the stage of dementia, the primary goal (cognition, behaviour, function or wellbeing), the person’s preferences and life history, and what is safely accessible. Here is a practical decision framework.
Identify the most pressing problem right now. Is it agitation? Sleep disruption? Declining independence in daily tasks? Social withdrawal? Name one primary target before choosing an intervention.
Match the intervention to the goal. Agitation and mood: music therapy, reminiscence, sensory approaches. Cognition and engagement: group CST, cognitive rehabilitation. Function and safety: exercise, OT, home modifications. Sleep and circadian rhythm: bright light therapy, consistent routines.
Check stage appropriateness. Group CST works best in mild to moderate dementia. Sensory and creative therapies remain effective into later stages when verbal engagement declines. Exercise can be adapted across all stages with appropriate supervision.
Obtain consent and involve the person. Where the person has capacity, their preferences should drive the choice. Where capacity is reduced, involve them as much as possible and use knowledge of their life history to guide decisions.
Set a measurable goal and record a baseline. Choose one simple measure: agitation frequency per day, sleep hours, a carer-rated quality-of-life score, or a short cognitive screen. Record it before starting.
Run a six to twelve week trial. Commit to one or two interventions consistently before evaluating. Most non-drug therapies need several weeks of regular use to show a meaningful signal.
Review with the GP or allied health team. Bring your log. Discuss whether to continue, adjust or try something different.
Questions to ask any programme provider before starting: What is the facilitator’s training and experience with dementia? What does a typical session look like? How will progress be measured? What is the expected timeline for seeing change? What happens if the person’s condition worsens during the programme?
What does the research actually show, and where are the gaps?
The evidence for non-pharmaceutical dementia treatment options is real but modest. The NCBI evidence review summarises multiple RCTs showing small to moderate short-term benefits from cognitive stimulation, exercise and music therapy across cognition, functional ability and wellbeing outcomes. The key word is short-term: long-term data is sparse, and study designs vary enough that pooling results is difficult.
What has the strongest evidence:
Exercise (Grade 1B): consistent RCT support for physical function and mood benefits.
Group cognitive stimulation therapy (Grade 2B): multiple RCTs showing cognition and quality-of-life improvements in mild to moderate dementia.
Psychosocial support for carers (Grade 2C): systematic review support for reducing carer stress and improving coping.
Where evidence is moderate or mixed:
Music therapy: strong short-term signals for agitation and mood; fewer long-term RCTs.
Reminiscence therapy: consistent mood and engagement benefits; cognition effects less clear.
OT and home modifications: strong face validity and practical benefit; fewer large RCTs.
Bright light therapy: useful for sleep and circadian disruption; cognitive effects less established.
Where evidence is weak or preliminary:
Aromatherapy and massage: small trials, short follow-up, meaningful for comfort but not cognition.
Supplements and herbal remedies: the Alzheimer’s Association is clear that compounds like ginkgo, coconut oil and huperzine A lack consistent high-quality evidence; no supplement is proven to prevent or treat Alzheimer’s disease.
Photobiomodulation: emerging signals from experimental and clinical studies; larger RCTs are still needed.
Statistic callout: The CCCDTD5 guideline grades exercise at 1B and group CST at 2B — the two highest-graded non-drug interventions in the guideline — based on systematic reviews and expert consensus.
Common limitations across the field: most trials are small (fewer than 100 participants), run for less than six months, and use heterogeneous outcome measures that make comparison difficult. Late-stage dementia is consistently under-researched. Effect sizes are often modest, which does not mean the interventions are not worth using — it means expectations should be realistic and personalised.
A modest effect on agitation or sleep quality can transform daily life for a carer and the person they support. That is worth pursuing, even when the effect size in a meta-analysis looks unimpressive on paper.
What is photobiomodulation and how does it fit into dementia care?
Photobiomodulation (PBM) is the use of specific red and near-infrared light wavelengths to stimulate biological processes at the cellular level. In plain terms: certain wavelengths of light, delivered at the right intensity and duration, are absorbed by mitochondria (the energy-producing structures inside cells) and appear to support cellular repair, reduce inflammation and improve energy production. This is distinct from bright light therapy, which works through the eyes and the circadian system. PBM works through the tissue itself.
For brain health applications, devices are typically placed on the scalp (transcranial delivery) or used in combination with intranasal delivery to reach deeper brain structures. The clinical light therapy research compiled by Lifespan Dynamics covers trial summaries and mechanistic findings relevant to cognitive and neurodegenerative conditions.
The signal is promising but not yet definitive. Larger, well-controlled RCTs are still needed before PBM can be placed alongside exercise or CST in terms of evidence grade. Stating otherwise would be overclaiming.
Practical protocol formats used in practice:
Session length: typically 10–20 minutes per session.
Frequency: three to five sessions per week in early protocols.
Placement: scalp (transcranial), intranasal, or combined depending on the device and target.
Setting: clinical delivery or supervised home use with appropriate devices.
Lifespan Dynamics publishes a practical early-stage dementia PBM protocol that explains session structure, device placement and monitoring for home use under clinical oversight. It is a useful starting point for anyone wanting to understand what a real protocol looks like before speaking with their GP.
Safety considerations: PBM is generally well-tolerated, but it is not appropriate for everyone. Contraindications and cautions include active photosensitising medications, a history of photosensitive epilepsy, active skin conditions or lesions at the treatment site, and use over the eyes without appropriate eye protection. Anyone with a pacemaker or implanted electronic device should seek medical advice before use.
Pro Tip:PBM works best as one layer within a multimodal plan, not as a replacement for exercise, cognitive stimulation or psychosocial support. Think of it as an adjunct that may support the cellular environment in which those other therapies do their work. Always discuss device use with your GP before starting, particularly if the person is on multiple medications.
Access in Australia: Lifespan Dynamics supplies red and near-infrared LED panels and pads for both clinical and home use, developed in collaboration with clinical researchers including Professor Sungkyoo Lim. Devices are available directly through the Lifespan Dynamics shop. Clinician-delivered PBM sessions are also available through some physiotherapy and integrative medicine clinics in major Australian cities.
Where can you get help in Australia?
Getting started with non-drug dementia care in Australia is more straightforward than many families realise. The key is knowing which door to knock on first.
National services and helplines:
Dementia Australia (1800 100 500): the primary national resource for people living with dementia and their carers. Offers information, counselling, group programmes, carer training and referrals to local services.
National Dementia Helpline (1800 100 500, operated by Dementia Australia): available seven days a week for information, emotional support and service navigation.
My Aged Care (1800 200 422 or myagedcare.gov.au): the federal government gateway for aged care assessments, home care packages, residential care and allied health referrals. An assessment here is the key that unlocks funded services.
Carer Gateway (1800 422 737 or carergateway.gov.au): free practical support, counselling, respite planning and peer connection for unpaid carers.
Typical referral pathway:
Start with the GP: request a cognitive assessment, a referral for a My Aged Care assessment, and a Chronic Disease Management plan for allied health sessions.
My Aged Care assessment: determines eligibility for home care packages, Commonwealth Home Support Programme services and equipment funding.
Allied health referral: physiotherapist, OT, psychologist or speech pathologist depending on the primary goal.
Community programmes: Dementia Australia groups, community health centre programmes and local council day programmes.
Statistic callout: My Aged Care assessments can unlock Home Care Packages at four levels of funding, from basic support to high-level care — an OT or allied health report is often the document that determines which level is approved.
If you want to start a non-drug intervention this month: call Dementia Australia (1800 100 500) and ask about group programmes in your area. Book a GP appointment to discuss a Chronic Disease Management plan. Download the My Aged Care referral form online or call to request an assessment. These three steps can be taken in parallel and typically open access within four to eight weeks.
When do you need medical review instead of a non-drug approach?
Non-drug therapies are powerful, but they are not the right first response to every situation. Some changes in a person with dementia signal a medical problem that needs urgent attention.
Red flags requiring prompt medical review:
Sudden or rapid cognitive decline over days (not weeks): this can indicate delirium, infection, stroke or medication toxicity.
New focal neurological signs: weakness on one side, sudden speech difficulty, facial drooping.
Severe falls or a fall with head injury.
Signs of infection: fever, confusion, pain on urination, productive cough.
Severe dehydration: dry mouth, dark urine, confusion, rapid heart rate.
Expressions of suicidal ideation or severe psychological distress.
Significant unexplained weight loss.
Contraindications and cautions for specific non-drug therapies:
Exercise: avoid high-intensity or unsupervised exercise in people with severe cardiovascular disease, recent fractures or significant fall risk without physiotherapy assessment first.
Bright light therapy: use with caution in people with macular degeneration, retinal conditions or photosensitive medications; always use devices designed for the purpose.
Photobiomodulation: contraindicated over active skin lesions, in people with photosensitive epilepsy, or in those on photosensitising medications without medical clearance.
Aromatherapy: some essential oils interact with medications or trigger respiratory reactions; check with the GP if the person has asthma or multiple drug sensitivities.
When to discuss medication with the GP or geriatrician: if non-drug strategies have been consistently applied for six to twelve weeks and severe agitation, psychosis, depression or sleep disorder remains unmanaged, a medication review is appropriate. Non-drug approaches are the preferred first line, not the only line.
Safety checklist for trialling any new intervention:
Confirm there are no contraindications with the GP before starting.
Record a baseline measure of the target symptom.
Introduce one new intervention at a time so you can attribute any change.
Document any adverse reactions (increased agitation, skin reactions, falls, sleep worsening) and stop the intervention if they occur.
Review with the GP or allied health team at six weeks.
The case for starting with what we know works
The conversation around dementia care has shifted considerably in the past decade. Families used to arrive at a GP appointment hoping for a medication that would fix things. Now, increasingly, they arrive asking about cognitive stimulation, exercise programmes and light therapy. That shift reflects something real: the evidence for non-drug approaches has matured, and the clinical community has caught up.
What strikes me most about the research is not the effect sizes — which are modest, as they are for most dementia interventions including medications — but the consistency of the signal across very different types of people and settings. Exercise helps. Cognitive stimulation helps. Addressing the carer’s stress helps. These are not fringe findings from small pilot studies; they carry guideline-level recommendations.
Where I think families and clinicians still underinvest is in the combination. A person doing group CST twice a week, walking daily, sleeping better because their circadian rhythm is supported, and living in a calmer, more predictable home environment is in a fundamentally different position than someone receiving only one of those things. The multimodal approach is where the real-world benefit compounds.
Photobiomodulation sits at an interesting point in that picture. The mechanistic rationale is sound, the early clinical signals are encouraging, and the safety profile is favourable. It is not yet at the evidence level of exercise or CST, so saying otherwise would be misleading. But as a supportive adjunct within a well-designed multimodal plan, it deserves serious consideration rather than dismissal. The clinical research Lifespan Dynamics has compiled is a good starting point for anyone who wants to read the evidence themselves before speaking with their clinician.
Individual responses vary. Clinical oversight matters. And the person living with dementia — their preferences, their history, their goals — should be at the centre of every decision.
Lifespan Dynamics and photobiomodulation for brain health
If you are exploring photobiomodulation as part of a broader dementia care plan, Lifespan Dynamics offers red and near-infrared LED panels and pads developed with clinical researchers for both home and clinical use. The brain health application page outlines the device options most relevant to cognitive support, and the at-home device guide explains how to integrate a device safely into a daily care routine.
Lifespan Dynamics also provides practitioner resources, protocol guides and clinical research summaries for healthcare professionals who want to incorporate PBM into a supervised care plan. Every device is built for durability and clinical-grade consistency, whether it is used in a clinic or at home.
Consult your GP or specialist before starting any new device-based therapy to confirm it is appropriate for your situation.
Yes. Non-pharmaceutical dementia treatment options including cognitive stimulation therapy, structured exercise, psychosocial support and sensory therapies have guideline-level recommendations and can meaningfully improve cognition, behaviour and quality of life, particularly in mild to moderate dementia. Medication may still be appropriate for specific symptoms, but non-drug approaches are the recommended first line.
How much do people with dementia typically sleep?
Sleep patterns in dementia are often disrupted, with people sleeping more during the day and waking frequently at night. Consistent daily routines, morning light exposure and reduced daytime napping are the most practical first steps; speak with the GP if sleep disruption is severe or sudden.
How does personality change in early dementia?
Early dementia commonly brings increased irritability, apathy, anxiety or social withdrawal, often before significant memory loss becomes obvious. These changes reflect the brain regions affected rather than the person’s character, and person-centred psychosocial approaches that address unmet needs tend to reduce their frequency and intensity.
What should you avoid saying to someone with memory loss?
Avoid correcting, testing or arguing with someone who has dementia. Phrases like “I just told you that” or “Don’t you remember?” increase distress without improving recall. Validation therapy — meeting the person in their emotional reality rather than correcting factual errors — is a more effective and kinder approach.
Is photobiomodulation safe to use at home for dementia?
PBM using red and near-infrared light devices is generally well-tolerated, but home use should be discussed with a GP first, particularly if the person takes photosensitising medications or has a history of photosensitive epilepsy. Lifespan Dynamics provides at-home safety guidance and protocol resources to support supervised use.
Non-pharmaceutical dementia treatment options: what helps most
The non-pharmaceutical dementia treatment options with the strongest evidence are cognitive stimulation therapy, structured exercise, psychosocial and carer-support programmes, sensory and creative therapies, environmental and assistive-technology changes, and photobiomodulation (red and near-infrared light therapy). Each targets a different dimension of living well with dementia: cognition, behaviour, mood, physical function, or quality of life. None of them cure dementia, but the right combination, chosen for the person’s stage and preferences, can meaningfully improve daily life.
Here is what the evidence supports most clearly, and what to do next:
Immediate next steps: pick one intervention that fits the person’s current stage, record a simple baseline (sleep quality, agitation frequency, or a short cognitive screen), involve the GP or geriatrician, and contact Dementia Australia or My Aged Care for local access.
Pro Tip: Start with the intervention that addresses the most pressing problem right now — agitation, sleep disruption, or social withdrawal — rather than trying to cover every category at once. A focused, measurable trial over six to twelve weeks tells you far more than a scattered approach.
Key takeaways
Evidence-backed non-pharmaceutical dementia treatment options work best when chosen by stage and goal, combined into a multimodal plan, and reviewed regularly with the GP or allied health team.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Table of Contents
How practitioners group non-pharmaceutical interventions
Clinicians and researchers organise non-pharmaceutical dementia treatment options into five practical groups, with photobiomodulation emerging as a sixth. Understanding the groups helps you pick the right tool for the right goal.
1. Cognitive interventions target memory, attention and reasoning. Expect modest improvements in cognition and quality of life, typically visible within six to twelve weeks of consistent group sessions.
2. Psychosocial and behavioural approaches address distress, agitation and carer stress. Benefits often appear within four to eight weeks of structured carer training or counselling.
3. Sensory and creative therapies focus on mood, engagement and agitation. Music therapy, for example, can reduce agitation during personal care within the first few sessions.
4. Physical activity and occupational therapy (OT) support physical function, fall prevention and independence in daily activities. Functional gains from exercise programmes typically build over eight to twelve weeks.
5. Environmental and assistive-technology changes reduce confusion, wandering risk and carer burden. Many of these are immediate in effect once implemented.
6. Photobiomodulation uses red and near-infrared light wavelengths to support cellular energy and comfort, with emerging signals for cognitive benefit. It works best as part of a multimodal plan rather than as a standalone therapy.
The honest framing is this: none of these reliably reverse dementia. What they do, when personalised to the individual’s history, stage and preferences, is help people live better. That is a meaningful goal in its own right.
What are the best non-pharmaceutical dementia treatment options for cognition?
Cognitive stimulation therapy (CST) is the most evidence-backed cognitive intervention for mild to moderate dementia. In plain terms, CST is a structured group programme — usually seven to fourteen weekly sessions — that uses themed activities like word games, current events discussions and sensory exercises to keep the brain engaged. It is not memory drilling; it is social, enjoyable and designed around the person’s strengths.
Cognitive rehabilitation takes a different angle. Rather than general stimulation, it works one-to-one with the person to set specific, personally meaningful goals — relearning how to use a phone, managing a morning routine — and builds strategies to achieve them. It suits mild dementia particularly well.
Memory training (repeated practice of specific memory techniques) has a narrower evidence base and tends to show smaller effects than CST, though it can complement other approaches.
The NCBI evidence review summarises multiple RCTs showing small to moderate short-term benefits from cognitive stimulation, with the caveat that long-term data is limited and study designs vary considerably. Group CST has the most consistent signal.
How to access CST in Australia:
What to ask before starting a cognitive programme:
How do psychosocial approaches reduce distress in dementia?
Behaviours like agitation, repetitive questioning and wandering are rarely random. They are usually communication. The person with dementia is signalling an unmet need — pain, boredom, fear, loneliness — and the most effective response is to identify and address that need rather than suppress the behaviour with medication.
Person-centred care is the foundation of this approach. It means understanding the person’s life history, preferences and values, and using that knowledge to shape every interaction. A person who spent their career as a nurse may respond very differently to being helped with personal care than someone who was a farmer. That context changes everything.
Behavioural management programmes train carers to log the antecedents, behaviour and consequences (the ABC model) of distressing episodes. Once patterns emerge, small environmental or routine changes often reduce the frequency significantly. This is practical, low-cost and teachable.
Psychoeducation and structured carer training programmes — such as those offered through Carer Gateway — give families the skills to manage difficult situations without burning out. The evidence for carer-focused psychosocial support is solid enough that the CCCDTD5 guideline gives it a Grade 2C recommendation.
Practical steps for introducing behavioural strategies at home:
Pro Tip: Carer burnout is one of the biggest risks in dementia care. Carer Gateway (1800 422 737) offers free counselling, respite planning and peer support — use it before you reach the point of crisis, not after.
Which sensory and creative therapies actually help?
Music therapy has the strongest evidence among sensory therapies. A trained music therapist uses live or recorded music — singing, instrument playing, or simply listening — to reduce agitation, improve mood and increase social engagement. The effect on agitation during personal care is one of the most replicated findings in dementia research. You do not need a formal therapist to start: familiar music from the person’s young adult years, played at a consistent time each day, can noticeably reduce distress.
Reminiscence therapy uses photographs, objects, music and stories from the person’s past to stimulate memory and conversation. It tends to improve mood and engagement rather than cognition directly, and it works well both one-to-one and in small groups. Dementia Australia’s non-pharmacological treatments page lists reminiscence alongside music and dance therapy as commonly used approaches with meaningful quality-of-life benefits.
Art and dance activities follow a similar pattern: moderate evidence for mood and engagement, weaker evidence for cognition, but strong practical value for people who struggle with verbal communication.
Aromatherapy and massage have a smaller evidence base. Both can reduce short-term agitation and improve comfort, particularly for people in moderate to late-stage dementia who may not engage well with verbal therapies. Lavender and lemon balm have the most studied profiles, though the Alzheimer’s Association cautions that no supplement or herbal remedy has consistent high-quality evidence for treating dementia itself.
Bright light therapy vs photobiomodulation: these are different things. Bright light therapy (typically 2,500–10,000 lux white light) targets circadian rhythm disruption and sleep problems, which are common in dementia. Photobiomodulation (PBM) uses specific red (630–670 nm) and near-infrared (810–850 nm) wavelengths at much lower intensities to support cellular energy at the mitochondrial level. Their aims, mechanisms and evidence bases are distinct. Lifespan Dynamics’ devices fall in the PBM category; more on that in the dedicated section below.
Where to find sensory and creative therapies in Australia:
How does exercise and occupational therapy help people with dementia?
Exercise is among the highest-graded non-drug interventions in the CCCDTD5 guideline, based on consistent evidence from multiple RCTs that regular physical activity supports physical function, mood and general health in people living with dementia. The evidence for slowing cognitive decline specifically is less definitive, but the functional and mood benefits alone justify making movement a daily priority.
What kinds of exercise help? Walking programmes are the most accessible starting point. Strength training (light resistance bands or bodyweight exercises) helps maintain muscle mass and reduce fall risk. Balance exercises — standing on one foot, heel-to-toe walking — directly address the fall risk that increases as dementia progresses. Aim for at least 30 minutes of moderate activity on most days, broken into shorter bouts if needed. Starting safely matters more than intensity: begin with what the person can already do comfortably and build gradually.
Occupational therapy (OT) sits alongside exercise as a practical, function-focused intervention. An OT assesses how the person manages daily activities — dressing, cooking, managing medications — and prescribes compensatory strategies and equipment to maintain independence for longer. OT also plays a key role in home safety assessments and assistive technology prescription.
Referral pathways in Australia: ask the GP for a referral to a physiotherapist or OT through a Chronic Disease Management plan (which may cover up to five Medicare-subsidised allied health sessions per year). My Aged Care assessments can also unlock home care packages that fund ongoing allied health support. Community exercise groups specifically designed for older adults with cognitive changes are available through local councils and community health centres in most areas.
Pro Tip: Before starting any new exercise programme, ask the GP to check for cardiovascular risk, osteoporosis and fall history. A simple timed-up-and-go test (standing from a chair, walking three metres, returning and sitting) takes under a minute and gives you a measurable baseline to track progress.
What home changes make the biggest difference for safety?
The environment is a low-cost, high-impact intervention that most families underestimate. Dementia progressively impairs the ability to interpret complex or unfamiliar environments, so simplifying the home reduces confusion, agitation and accident risk without any clinical referral needed.
Dementia-friendly home principles: familiarity over novelty, reduced clutter, clear visual cues, consistent routines, and good lighting. A person with dementia navigates their world largely through habit and recognition. Rearranging furniture, even with good intentions, can be genuinely disorienting.
Safety checklist for the home:
Assistive technology worth considering includes medication reminder devices (automated dispensers with alarms), large-button phones, movement sensors that alert carers to unusual activity, and electronic calendars with voice reminders. The evidence base for specific devices is limited, but practical benefit in daily life is well-documented by OTs and carers.
Funding and support in Australia: a My Aged Care assessment can fund an OT home safety assessment and equipment prescription. Local council programs (under the Commonwealth Home Support Programme) often cover minor home modifications. Ask the OT for a written report — it is frequently the document that unlocks funding.
Pro Tip: The single most underrated environmental intervention is a consistent daily routine. Predictable mealtimes, activity times and bedtimes reduce agitation because the person’s nervous system learns what to expect. A calm, unhurried carer presence reinforces that predictability in a way no device can replicate.
How do you choose the right intervention for your situation?
The right non-drug approach depends on four things: the stage of dementia, the primary goal (cognition, behaviour, function or wellbeing), the person’s preferences and life history, and what is safely accessible. Here is a practical decision framework.
Questions to ask any programme provider before starting: What is the facilitator’s training and experience with dementia? What does a typical session look like? How will progress be measured? What is the expected timeline for seeing change? What happens if the person’s condition worsens during the programme?
What does the research actually show, and where are the gaps?
The evidence for non-pharmaceutical dementia treatment options is real but modest. The NCBI evidence review summarises multiple RCTs showing small to moderate short-term benefits from cognitive stimulation, exercise and music therapy across cognition, functional ability and wellbeing outcomes. The key word is short-term: long-term data is sparse, and study designs vary enough that pooling results is difficult.
What has the strongest evidence:
Where evidence is moderate or mixed:
Where evidence is weak or preliminary:
Common limitations across the field: most trials are small (fewer than 100 participants), run for less than six months, and use heterogeneous outcome measures that make comparison difficult. Late-stage dementia is consistently under-researched. Effect sizes are often modest, which does not mean the interventions are not worth using — it means expectations should be realistic and personalised.
A modest effect on agitation or sleep quality can transform daily life for a carer and the person they support. That is worth pursuing, even when the effect size in a meta-analysis looks unimpressive on paper.
What is photobiomodulation and how does it fit into dementia care?
Photobiomodulation (PBM) is the use of specific red and near-infrared light wavelengths to stimulate biological processes at the cellular level. In plain terms: certain wavelengths of light, delivered at the right intensity and duration, are absorbed by mitochondria (the energy-producing structures inside cells) and appear to support cellular repair, reduce inflammation and improve energy production. This is distinct from bright light therapy, which works through the eyes and the circadian system. PBM works through the tissue itself.
For brain health applications, devices are typically placed on the scalp (transcranial delivery) or used in combination with intranasal delivery to reach deeper brain structures. The clinical light therapy research compiled by Lifespan Dynamics covers trial summaries and mechanistic findings relevant to cognitive and neurodegenerative conditions.
The signal is promising but not yet definitive. Larger, well-controlled RCTs are still needed before PBM can be placed alongside exercise or CST in terms of evidence grade. Stating otherwise would be overclaiming.
Practical protocol formats used in practice:
Lifespan Dynamics publishes a practical early-stage dementia PBM protocol that explains session structure, device placement and monitoring for home use under clinical oversight. It is a useful starting point for anyone wanting to understand what a real protocol looks like before speaking with their GP.
Safety considerations: PBM is generally well-tolerated, but it is not appropriate for everyone. Contraindications and cautions include active photosensitising medications, a history of photosensitive epilepsy, active skin conditions or lesions at the treatment site, and use over the eyes without appropriate eye protection. Anyone with a pacemaker or implanted electronic device should seek medical advice before use.
Pro Tip: PBM works best as one layer within a multimodal plan, not as a replacement for exercise, cognitive stimulation or psychosocial support. Think of it as an adjunct that may support the cellular environment in which those other therapies do their work. Always discuss device use with your GP before starting, particularly if the person is on multiple medications.
Access in Australia: Lifespan Dynamics supplies red and near-infrared LED panels and pads for both clinical and home use, developed in collaboration with clinical researchers including Professor Sungkyoo Lim. Devices are available directly through the Lifespan Dynamics shop. Clinician-delivered PBM sessions are also available through some physiotherapy and integrative medicine clinics in major Australian cities.
Where can you get help in Australia?
Getting started with non-drug dementia care in Australia is more straightforward than many families realise. The key is knowing which door to knock on first.
National services and helplines:
Typical referral pathway:
If you want to start a non-drug intervention this month: call Dementia Australia (1800 100 500) and ask about group programmes in your area. Book a GP appointment to discuss a Chronic Disease Management plan. Download the My Aged Care referral form online or call to request an assessment. These three steps can be taken in parallel and typically open access within four to eight weeks.
When do you need medical review instead of a non-drug approach?
Non-drug therapies are powerful, but they are not the right first response to every situation. Some changes in a person with dementia signal a medical problem that needs urgent attention.
Red flags requiring prompt medical review:
Contraindications and cautions for specific non-drug therapies:
When to discuss medication with the GP or geriatrician: if non-drug strategies have been consistently applied for six to twelve weeks and severe agitation, psychosis, depression or sleep disorder remains unmanaged, a medication review is appropriate. Non-drug approaches are the preferred first line, not the only line.
Safety checklist for trialling any new intervention:
The case for starting with what we know works
The conversation around dementia care has shifted considerably in the past decade. Families used to arrive at a GP appointment hoping for a medication that would fix things. Now, increasingly, they arrive asking about cognitive stimulation, exercise programmes and light therapy. That shift reflects something real: the evidence for non-drug approaches has matured, and the clinical community has caught up.
What strikes me most about the research is not the effect sizes — which are modest, as they are for most dementia interventions including medications — but the consistency of the signal across very different types of people and settings. Exercise helps. Cognitive stimulation helps. Addressing the carer’s stress helps. These are not fringe findings from small pilot studies; they carry guideline-level recommendations.
Where I think families and clinicians still underinvest is in the combination. A person doing group CST twice a week, walking daily, sleeping better because their circadian rhythm is supported, and living in a calmer, more predictable home environment is in a fundamentally different position than someone receiving only one of those things. The multimodal approach is where the real-world benefit compounds.
Photobiomodulation sits at an interesting point in that picture. The mechanistic rationale is sound, the early clinical signals are encouraging, and the safety profile is favourable. It is not yet at the evidence level of exercise or CST, so saying otherwise would be misleading. But as a supportive adjunct within a well-designed multimodal plan, it deserves serious consideration rather than dismissal. The clinical research Lifespan Dynamics has compiled is a good starting point for anyone who wants to read the evidence themselves before speaking with their clinician.
Individual responses vary. Clinical oversight matters. And the person living with dementia — their preferences, their history, their goals — should be at the centre of every decision.
Lifespan Dynamics and photobiomodulation for brain health
If you are exploring photobiomodulation as part of a broader dementia care plan, Lifespan Dynamics offers red and near-infrared LED panels and pads developed with clinical researchers for both home and clinical use. The brain health application page outlines the device options most relevant to cognitive support, and the at-home device guide explains how to integrate a device safely into a daily care routine.
Lifespan Dynamics also provides practitioner resources, protocol guides and clinical research summaries for healthcare professionals who want to incorporate PBM into a supervised care plan. Every device is built for durability and clinical-grade consistency, whether it is used in a clinic or at home.
Consult your GP or specialist before starting any new device-based therapy to confirm it is appropriate for your situation.
Sources
FAQ
Can dementia be treated without medication?
Yes. Non-pharmaceutical dementia treatment options including cognitive stimulation therapy, structured exercise, psychosocial support and sensory therapies have guideline-level recommendations and can meaningfully improve cognition, behaviour and quality of life, particularly in mild to moderate dementia. Medication may still be appropriate for specific symptoms, but non-drug approaches are the recommended first line.
How much do people with dementia typically sleep?
Sleep patterns in dementia are often disrupted, with people sleeping more during the day and waking frequently at night. Consistent daily routines, morning light exposure and reduced daytime napping are the most practical first steps; speak with the GP if sleep disruption is severe or sudden.
How does personality change in early dementia?
Early dementia commonly brings increased irritability, apathy, anxiety or social withdrawal, often before significant memory loss becomes obvious. These changes reflect the brain regions affected rather than the person’s character, and person-centred psychosocial approaches that address unmet needs tend to reduce their frequency and intensity.
What should you avoid saying to someone with memory loss?
Avoid correcting, testing or arguing with someone who has dementia. Phrases like “I just told you that” or “Don’t you remember?” increase distress without improving recall. Validation therapy — meeting the person in their emotional reality rather than correcting factual errors — is a more effective and kinder approach.
Is photobiomodulation safe to use at home for dementia?
PBM using red and near-infrared light devices is generally well-tolerated, but home use should be discussed with a GP first, particularly if the person takes photosensitising medications or has a history of photosensitive epilepsy. Lifespan Dynamics provides at-home safety guidance and protocol resources to support supervised use.
Recommended